Beta test rollout. This site is in community QA — please send feature requests, bug reports and data corrections on the Feedback page or on GitHub.

Home
    Disclaimer

    Salvia divinorum Stats & Data

    Sally Sally d Magic mint Seer's sage Diviner's sage Salvia
    Chemical Class Botanical preparation
    Psychoactive Class Psychedelic

    Subjective Effects

    Physical
    • Gravity alterations: This is consistently the most obvious and noticeable subjective physical experience during the onset of a moderate to high dosage salvia trip. It creates the sensation of an extremely powerful, irresistible and extradimensional force pulling the body and head in a specific direction, usually to the left or right.
    • Changes in felt bodily form: This effect often accompanies the onset of powerful salvinorin A gravity and can be described as non-painful sensations of being stretched horizontally or vertically into infinity, splitting into two halves and a variety of other sudden changes.
    • Spontaneous tactile sensations: For some unlucky people this is sometimes accompanied by the sensation of intense, sharp and cold pins and needles all over a person's skin, which can quickly become very uncomfortable. Most people however will never experience this feeling.
    Cognitive

    The general head space of salvia is described by many as one of extreme cognitive suppression and strong feelings of confusion. This substance is best described as a drug that does not create profound personal insights, just profound and interesting experiences.

    • Extreme laughter: The average first time salvia user generally experiences a mixture of extreme gigglyness and confusion.
    • Ego suppression, loss and death: This substance is particularly intense in its cognitive effects due to the near instant transition from sobriety into ego death which can occur very suddenly at moderate to high dosages.
    • Thought deceleration
    • Information processing suppression
    • Language suppression
    • Anxiety: General paranoia, anxiety and panic are very common for the unprepared.
    • Unity and interconnectedness
    • Amnesia
    Sensory
    Visual · Distortions

    When a user keeps their eyes open throughout the duration of a moderate to strong trip, a number of open eye distortions are usually present. These are significantly more simplistic than distortions found with other classes of hallucinogens.

    • Depth perception distortions: This effect is usually characterized by a total loss of depth perception and a complete flattening of the visual field into a 2-dimensional image. It can also make objects seem further away or closer in distance than they actually are.
    • Size distortions: This effect can be described as specific objects within the external environment or the surroundings as a whole changing in physical size and becoming impossibly huge or small in size.
    Visual · Hallucinatory States

    Salvia produces a full range of high level hallucinatory states in a fashion that is just as consistent as that of classical psychedelics.

    • External hallucinations: In comparison to psychedelics, the transformations found within salvinorin A are significantly more solid, believable and realistic in appearance. They are commonly manifested as objects within the external environment coming alive or changing in some way and can only occur when the eyes are kept open.
    • Internal hallucinations: (Autonomous entities; settings, sceneries, and landscapes; alterations in perspective and scenarios and plots)
    • Machinescapes: At high dosages with darkness or closed eyes, once the user has become disconnected from their body, vast and complex landscapes comprised of ever-changing and interlocking mechanical parts manifest. These are comprised from an infinite variety of potential materials and parts which often comprise impossible arrays of cogs, gears, pulleys, conveyor belts, levers, panels, hydraulics and incomprehensible moving parts. There is an extremely prominent sense that you have become the perceivable machinescape.
    Auditory
    • Distortions
    • Hallucinations

    Forked from Subjective Effect Documentation by Josie Kins, March 2012. Via dose.wiki (CC0).

    Duration Timeline

    Bluelight
    Onset Comeup Peak Offset After Effects
    Smoked (Dried Leaf)
    0-1 minutes
    4-19 minutes
    10-30 minutes
    15 minutes - 1.0 hours
    Smoked (5X Extract)
    0-1 minutes
    4-19 minutes
    10-30 minutes
    15 minutes - 1.0 hours
    Smoked (10X Extract)
    0-1 minutes
    4-19 minutes
    10-30 minutes
    15 minutes - 1.0 hours
    Sublingual/Quid (Fresh Leaf)
    10-19 minutes
    30 minutes - 1.0 hours
    30 minutes - 1.5 hours
    1-2 hours
    Sublingual/Quid (Dried Leaf)
    10-19 minutes
    30 minutes - 1.0 hours
    30 minutes - 1.5 hours
    1-2 hours
    Vaporized (Pure Salvinorin A)
    0-1 minutes
    1-10 minutes
    10-19 minutes
    15 minutes - 1.0 hours

    Empirical Duration

    Erowid Reports

    Median times after the dose that Erowid reports state. A curve is drawn only when reports state all four points (onset, peak begins, comedown begins, back to baseline) and the medians fall in that order. No point is estimated from another.

    Smoked (175 reports)
    Onset T+20min12 reports Peak begins T+10min40 reports Comedown begins T+15min59 reports Back to baseline T+15min81 reports

    No curve: the stated times run backwards. Reports put the start of the peak (T+10min, 40 reports) before the onset (T+20min, 12 reports). Reports put the start of the comedown (T+15min, 59 reports) before the onset (T+20min, 12 reports). Reports put the return to baseline (T+15min, 81 reports) before the onset (T+20min, 12 reports). Each time is the median of a different set of reports, so they are shown as stated, not rearranged.

    Community Effects

    TripSit
    Positive
    euphoria visual enhancement mood lift dissociation
    Negative
    addiction

    Experience Report Analysis

    Erowid BlueLight
    2,203 Reports
    1,660 Single-substance
    1995–2025 Date Range
    504 With Age Data
    30 Effects Detected

    Demographics

    Gender Distribution

    Age Distribution

    Reports Over Time

    Effect Analysis

    Erowid + Bluelight

    Effects aggregated from 1,710 experience reports (1,660 single-substance Erowid + 372 Bluelight)

    1,710 Reports
    140 Effects Detected
    48 Positive
    62 Adverse
    30 Neutral

    Effect Sentiment Distribution

    Confidence Distribution

    Each bar is the share of reports mentioning the effect; its whisker, and the band on the rows below, is the 95% interval: where the share could plausibly be with other reports of the same kind.

    Positive Effects 48

    Visual Distortions 40.9% (95% interval 39 to 43 percent) 85%
    Color Enhancement 31.2% (95% interval 29 to 34 percent) 83%
    Awe 30.0% (95% interval 19 to 44 percent) 83%
    Geometric Imagery 28.0% (95% interval 18 to 42 percent) 88%
    Music Enhancement 23.7% (95% interval 22 to 26 percent) 70%
    Closed-Eye Visuals 21.2% (95% interval 19 to 23 percent) 87%
    Empathy 20.4% (95% interval 19 to 22 percent) 85%
    Stimulation 18.3% (95% interval 16 to 20 percent) 76%
    Euphoria 16.4% (95% interval 15 to 18 percent) 87%
    Introspection 15.2% (95% interval 14 to 17 percent) 82%
    Tactile Enhancement 12.4% (95% interval 11 to 14 percent) 85%
    Insight 12.0% (95% interval 6 to 24 percent) 83%
    Mystical Quality 10.0% (95% interval 4 to 21 percent) 87%
    Joy 10.0% (95% interval 4 to 21 percent) 87%
    Wonder 10.0% (95% interval 4 to 21 percent) 83%
    Open-Eye Visuals 9.8% (95% interval 8 to 11 percent) 80%
    Body High 8.5% (95% interval 7 to 10 percent) 84%
    Visual Fragmentation 8.0% (95% interval 3 to 19 percent) 81%
    Visual Vibration 8.0% (95% interval 3 to 19 percent) 81%
    Fractal Imagery 8.0% (95% interval 3 to 19 percent) 89%

    Adverse Effects 62

    Fear 62.0% (95% interval 48 to 74 percent) 89%
    Anxiety 58.6% (95% interval 56 to 61 percent) 84%
    Thought Disorganization 50.0% (95% interval 37 to 63 percent) 81%
    Depersonalization 48.0% (95% interval 35 to 62 percent) 84%
    Body Load 38.0% (95% interval 26 to 52 percent) 77%
    Confusion 36.8% (95% interval 34 to 39 percent) 87%
    Entity Imagery 32.0% (95% interval 21 to 46 percent) 87%
    Panic 30.0% (95% interval 19 to 44 percent) 89%
    Scene Replacement 20.0% (95% interval 11 to 33 percent) 90%
    Environmental Transfiguration 18.0% (95% interval 10 to 31 percent) 85%
    Body Distortion 18.0% (95% interval 10 to 31 percent) 90%
    Temporal Disorientation 16.0% (95% interval 8 to 28 percent) 85%
    Memory Suppression 15.8% (95% interval 14 to 18 percent) 81%
    Derealization 12.0% (95% interval 6 to 24 percent) 88%
    Ataxia 10.0% (95% interval 4 to 21 percent) 78%
    Heaviness 10.0% (95% interval 4 to 21 percent) 81%
    Time Looping 10.0% (95% interval 4 to 21 percent) 88%
    Delusion 10.0% (95% interval 4 to 21 percent) 85%
    Sweating 8.0% (95% interval 7 to 9 percent) 82%
    Motor Impairment 8.0% (95% interval 7 to 9 percent) 79%
    ⚠ Psychosis 3.0% (95% interval 2 to 4 percent) 70%
    ⚠ Seizure 0.5% (95% interval 0 to 1 percent) 70%
    Show 40 more adverse effects
    Paranoia 8.0% (95% interval 3 to 19 percent) 80%
    Amnesia 6.0% (95% interval 2 to 16 percent) 83%
    Dysphoria 6.0% (95% interval 2 to 16 percent) 88%
    Out-Of-Body Experience 6.0% (95% interval 2 to 16 percent) 87%
    Involuntary Movements 6.0% (95% interval 2 to 16 percent) 80%
    Sadness 6.0% (95% interval 2 to 16 percent) 83%
    Tremor 6.0% (95% interval 2 to 16 percent) 77%
    Pressure 6.0% (95% interval 2 to 16 percent) 80%
    Identity Alteration 6.0% (95% interval 2 to 16 percent) 87%
    Thought Loops 4.0% (95% interval 1 to 14 percent) 80%
    Social Anxiety 4.0% (95% interval 1 to 14 percent) 72%
    Dizziness 4.0% (95% interval 1 to 14 percent) 88%
    Self-Multiplication 4.0% (95% interval 1 to 14 percent) 88%
    Sociability Suppression 4.0% (95% interval 1 to 14 percent) 72%
    Dread 4.0% (95% interval 1 to 14 percent) 90%
    Morphing 4.0% (95% interval 1 to 14 percent) 81%
    Communication Suppression 4.0% (95% interval 1 to 14 percent) 75%
    Headache 2.7% (95% interval 2 to 4 percent) 75%
    Increased Heart Rate 2.7% (95% interval 2 to 4 percent) 70%
    Nausea 2.5% (95% interval 2 to 3 percent) 75%
    Jaw Clenching 2.4% (95% interval 2 to 3 percent) 70%
    Muscle Tension 2.2% (95% interval 2 to 3 percent) 70%
    Doom 2.0% (95% interval 0 to 10 percent) 85%
    Pain Enhancement 2.0% (95% interval 0 to 10 percent) 80%
    Longing 2.0% (95% interval 0 to 10 percent) 85%
    Perceived Inanimate Transformation 2.0% (95% interval 0 to 10 percent) 85%
    Resentment 2.0% (95% interval 0 to 10 percent) 80%
    Disappointment 2.0% (95% interval 0 to 10 percent) 80%
    Paranoid Ideation 2.0% (95% interval 0 to 10 percent) 85%
    Loneliness 2.0% (95% interval 0 to 10 percent) 70%
    Chills 2.0% (95% interval 0 to 10 percent) 85%
    Irritability 2.0% (95% interval 0 to 10 percent) 82%
    Emotional Pain 2.0% (95% interval 0 to 10 percent) 85%
    Taste Distortion 2.0% (95% interval 0 to 10 percent) 75%
    Vertigo 2.0% (95% interval 0 to 10 percent) 80%
    Field Widening 2.0% (95% interval 0 to 10 percent) 75%
    Perceived Theriomorphosis 2.0% (95% interval 0 to 10 percent) 90%
    Insomnia 2.0% (95% interval 0 to 10 percent) 75%
    Tactile Hallucination 2.0% (95% interval 0 to 10 percent) 85%
    Skin Crawling 2.0% (95% interval 0 to 10 percent) 75%
    Show 30 neutral or unclassified mentions
    Dissociation 21.4% (95% interval 20 to 23 percent)
    Auditory Effects 20.9% (95% interval 19 to 23 percent)
    Time Dilation 20.0% (95% interval 11 to 33 percent)
    Patterning 14.0% (95% interval 7 to 26 percent)
    Time Distortion 10.3% (95% interval 9 to 12 percent)
    Ego Dissolution 8.8% (95% interval 8 to 10 percent)
    Deja Vu 8.0% (95% interval 3 to 19 percent)
    Sedation 7.9% (95% interval 7 to 9 percent)
    Tingling 6.0% (95% interval 2 to 16 percent)
    Memory Enhancement 6.0% (95% interval 2 to 16 percent)
    Contact-With-Presence 6.0% (95% interval 2 to 16 percent)
    Warping 6.0% (95% interval 2 to 16 percent)
    Cosmic Significance 4.0% (95% interval 1 to 14 percent)
    Surface Breathing 4.0% (95% interval 1 to 14 percent)
    Hospital 2.7% (95% interval 2 to 4 percent)
    Identity Confusion 2.0% (95% interval 0 to 10 percent)
    Analysis Enhancement 2.0% (95% interval 0 to 10 percent)
    Lightness 2.0% (95% interval 0 to 10 percent)
    Peripheral Imagery 2.0% (95% interval 0 to 10 percent)
    Field Narrowing 2.0% (95% interval 0 to 10 percent)
    Social Change 2.0% (95% interval 0 to 10 percent)
    Emotional Lability 2.0% (95% interval 0 to 10 percent)
    Time Compression 2.0% (95% interval 0 to 10 percent)
    Time Stopping 2.0% (95% interval 0 to 10 percent)
    Amazement 2.0% (95% interval 0 to 10 percent)
    Salivation 2.0% (95% interval 0 to 10 percent)
    Blurred Vision 2.0% (95% interval 0 to 10 percent)
    Body Temperature Change 2.0% (95% interval 0 to 10 percent)
    Afterimages 2.0% (95% interval 0 to 10 percent)
    Motor Change 2.0% (95% interval 0 to 10 percent)

    Also reported in combinations. In the 543 Salvia divinorum reports where another drug was taken too, 22 (4.1%) mention hospital, emergency services or an overdose, 6 (1.1%) a seizure and 25 (4.6%) psychosis. In the 1,660 single-substance reports: 2.7%, 0.5% and 3.0%. One or more of the three comes up more often in the combination reports (8.7% against 5.8%), by more than chance would explain; that does not show the combination caused it. These are not in the figures above: they cannot be put down to Salvia divinorum alone, and a mention is not always something that happened to the writer.

    Dose-Response Correlation

    How effect frequency changes across dose levels. Whiskers, and the numbers' hover text, give each figure's 95% interval.

    View data table
    Effect Threshold (n=292)
    Anxiety 61.3% (95% interval 56 to 67 percent)
    Visual Distortions 48.6% (95% interval 43 to 54 percent)
    Confusion 43.5% (95% interval 38 to 49 percent)
    Color Enhancement 31.8% (95% interval 27 to 37 percent)
    Music Enhancement 26.4% (95% interval 22 to 32 percent)
    Closed-Eye Visuals 23.3% (95% interval 19 to 28 percent)
    Auditory Effects 23.3% (95% interval 19 to 28 percent)
    Empathy 23.3% (95% interval 19 to 28 percent)
    Dissociation 22.9% (95% interval 18 to 28 percent)
    Euphoria 19.5% (95% interval 15 to 24 percent)
    Introspection 18.2% (95% interval 14 to 23 percent)
    Stimulation 17.8% (95% interval 14 to 23 percent)
    Memory Suppression 17.1% (95% interval 13 to 22 percent)
    Tactile Enhancement 15.8% (95% interval 12 to 20 percent)
    Time Distortion 11.6% (95% interval 8 to 16 percent)

    Subjective Effect Ontology

    Experience Reports

    Structured effect tags extracted from 2,247 Erowid & Bluelight experience reports using a controlled vocabulary of 220+ canonical effects across 15 domains.

    Auditory

    music enhancement 617 28.1% (95% interval 26 to 30 percent) auditory effects 496 22.1% (95% interval 20 to 24 percent)

    Cognitive

    confusion 831 37.0% (95% interval 35 to 39 percent) focus enhancement 406 18.5% (95% interval 17 to 20 percent) introspection 367 16.3% (95% interval 15 to 18 percent) memory suppression 366 16.3% (95% interval 15 to 18 percent)

    Emotional

    anxiety 1167 51.9% (95% interval 50 to 54 percent) empathy 495 22.0% (95% interval 20 to 24 percent) euphoria 441 19.6% (95% interval 18 to 21 percent)

    Motor

    stimulation 450 20.0% (95% interval 18 to 22 percent) sedation 194 8.6% (95% interval 8 to 10 percent) motor impairment 183 8.1% (95% interval 7 to 9 percent)

    Selfhood

    dissociation 508 22.6% (95% interval 21 to 24 percent) ego dissolution 201 9.0% (95% interval 8 to 10 percent)

    Somatic

    body high 204 9.1% (95% interval 8 to 10 percent) sweating 180 8.0% (95% interval 7 to 9 percent)

    Tactile

    tactile enhancement 588 26.2% (95% interval 24 to 28 percent)

    Temporal

    time distortion 238 10.6% (95% interval 9 to 12 percent)

    Visual

    visual distortions 1022 45.5% (95% interval 43 to 48 percent) color enhancement 735 32.7% (95% interval 31 to 35 percent) closed eye visuals 506 22.5% (95% interval 21 to 24 percent) open eye visuals 255 11.4% (95% interval 10 to 13 percent)

    22 unique effects extracted · Derived from Erowid & Bluelight reports

    Dose–Effect Mapping

    Experience Reports

    How reported effects shift across dose tiers, based on 1660 single-substance experience reports. The shaded band on each bar is its 95% interval. An arrow (↑ ↓) marks a change between the lowest and highest tier that count an effect only when the gap is bigger than chance would explain; ~ means no clear change. How changes are called

    Limited tier coverage — most reports fall within the Threshold range. Effects at other dose levels may not be represented.

    Effect Threshold (n=292) Change with dose
    anxiety
    61% (95% interval 56 to 67 percent)
    visual distortions
    49% (95% interval 43 to 54 percent)
    confusion
    44% (95% interval 38 to 49 percent)
    color enhancement
    32% (95% interval 27 to 37 percent)
    music enhancement
    26% (95% interval 22 to 32 percent)
    closed-eye visuals
    23% (95% interval 19 to 28 percent)
    auditory effects
    23% (95% interval 19 to 28 percent)
    empathy
    23% (95% interval 19 to 28 percent)
    dissociation
    23% (95% interval 18 to 28 percent)
    euphoria
    20% (95% interval 15 to 24 percent)
    introspection
    18% (95% interval 14 to 23 percent)
    stimulation
    18% (95% interval 14 to 23 percent)
    memory suppression
    17% (95% interval 13 to 22 percent)
    tactile enhancement
    16% (95% interval 12 to 20 percent)
    time distortion
    12% (95% interval 8 to 16 percent)
    sweating
    11% (95% interval 8 to 15 percent)
    body high
    11% (95% interval 8 to 15 percent)
    open-eye visuals
    11% (95% interval 8 to 15 percent)
    motor impairment
    10% (95% interval 7 to 14 percent)
    focus enhancement
    8% (95% interval 6 to 12 percent)

    Showing top 20 of 32 effects

    Dosage Distribution

    Dose distribution from experience reports, one dose per report (the first listed). Doses above Q3 + 3×IQR, far above what people typically take, are left out of the median and range and listed under each route: most are real heavy doses or overdoses, not mistakes.

    Median: 200.0 mg IQR: 100.0–333.3 mg n=369

    13 reports gave a dose above the typical range (1,750–7,000 mg), so they are not in the figures above. Listing a dose here does not mean it is safe.

    Show the reports

    Real-World Dose Distribution

    Erowid

    From 569 of 2294 recorded dose entries: those that state a weight (mg, g or µg), in routes with at least five of them. Values above Q3 + 3×IQR, far above what people typically take, are left out; they can include real heavy doses and overdoses, not only mistakes.

    Sublingual (n=39)

    Median: 2000.0mg 25th: 250.0mg 75th: 4425.0mg 90th: 6800.0mg

    Smoked (n=501)

    Median: 166.0mg 25th: 100.0mg 75th: 330.0mg 90th: 500.0mg

    Oral (n=7)

    Median: 1000.0mg 25th: 500.0mg 75th: 1750.0mg 90th: 5500.0mg

    Common Combinations

    Most co-occurring substances, as a share of all 2,203 reports filed under Salvia divinorum; whiskers are 95% intervals

    Form / Preparation

    Most common forms and preparations, as a share of the 1,997 reports that give one; whiskers are 95% intervals

    Body-Weight Dosing

    Dose per kg of body weight, one dose per report (the first listed), from reports giving a weight of 30–250 kg. Doses above Q3 + 3×IQR, far above what people typically take, are left out of the median and range and listed under each route.

    Smoked

    Median: 2.438 mg/kg IQR: 1.259–4.898 mg/kg n=348

    17 reports gave a dose above the typical range (18.382–84.746 mg/kg), so they are not in the figures above. Listing a dose here does not mean it is safe.

    Show the reports

    Unknown

    Median: 51.094 mg/kg IQR: 32.395–95.583 mg/kg n=16

    1 report gave a dose above the typical range (682.667 mg/kg), so it is not in the figures above. Listing a dose here does not mean it is safe.

    Show the report

    Sublingual

    Median: 26.704 mg/kg IQR: 12.668–36.64 mg/kg n=6

    Oral

    Median: 16.418 mg/kg IQR: 9.499–26.161 mg/kg n=6

    Redose Patterns

    Redosing behavior across 2032 reports

    9.8% (95% interval 9 to 11 percent) Redosed
    1.1 Avg Doses
    14m Median Interval
    ← Back to Salvia divinorum